Vimarsana
Biggest News Aggregation in the World

Page 4 - Inform Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inform Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inform Diagnostics Today - Breaking & Trending Today

Private Equity Holding AG: Net Asset Value as of June, 2022 - Vimarsana News

Private Equity Holding AG: Net Asset Value as of June, 2022

Private Equity Holding AG / Key word(s): Net Asset Value Private Equity Holding AG: Net Asset Value as of June, 2022 11.07.202...

The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test - Vimarsana News

The American Medical Association Approves a New Category I CPT® Code for the HelioLiver™ Test

/PRNewswire/ -- Helio Genomics ("Helio"), and its commercial partner, Fulgent Genetics (NASDAQ: FLGT) ("Fulgent") announced that the American Medical...

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q1 2022 Results - Earnings Call Transcript

Fulgent Genetics, Inc. (NASDAQ:NASDAQ:FLGT) Q1 2022 Earnings Conference Call May 3, 2022, 04:30 PM ET Company Participants Nicole Borsje - IR Ming Hsieh - CEO Brandon Perthuis - Chief...

Healthcare & Life Sciences Private Equity Deal Tracker: Avista Sells Inform Diagnostics to Fulgent Genetics | McGuireWoods LLP - Vimarsana News

Healthcare & Life Sciences Private Equity Deal Tracker: Avista Sells Inform Diagnostics to Fulgent Genetics | McGuireWoods LLP

Avista Capital Partners has announced it has closed on the sale of Inform Diagnostics to Fulgent Genetics for approximately $170 million. Inform Diagnostics, based in...

This Stock Grew 135% Last Year and Is Down 50% From Its Highs - Vimarsana News

This Stock Grew 135% Last Year and Is Down 50% From Its Highs

Is Fulgent an underrated stock or a value trap?

Source: fool.com